Egyptian e-health startup Nawah Scientific raises funding Cairo Angels Syndicate Fund

Nawah Scientific, an Egyptian life sciences and biotech startup, has received funding from the Cairo Angels Syndicate Fund (CASF) as part of its ongoing Series A round.

Nawah Scientific, which was founded in 2015, is an online platform that receives experiment requests, collects samples, conducts tests, and digitally returns results. Its goal is to allow scientists to conduct higher-quality research regardless of their location or lab facilities ownership.

The startup has established itself as an essential component of Egypt’s pharmaceutical industry, having analyzed over 200,000 samples from clients in 12 countries.

Following the completion of a US$1 million pre-Series A round earlier this year, Nawah Scientific is now working on a Series A round, and has secured capital from the Cairo Angels Syndicate Fund (CASF), a micro venture capital fund that invests in early-stage startups in the Middle East and Africa. The Cairo Angels network first invested in Nawah Scientific in 2020, and this round of funding is intended to assist the startup in maintaining its growth and onboarding new projects.

“As early investors, we had the honor of having individual angel investors from the Cairo Angels network.” They stepped in when we needed it the most, providing us with capital, networking, support, and, most importantly, faith in what we were building. “Now, Cairo Angels has joined us with their Syndicate Fund to build on the success we’ve achieved together, and I’m very excited about what’s to come,” said Dr. Omar Sakr, founder and CEO of Nawah Scientific.

“Dr. Omar is a perfect example of what I call “brain regain,” a super talented and ambitious founder who, to be honest, we would have lost in previous years to North America or Europe if it hadn’t been for recent changes that have allowed entrepreneurs to succeed at home.” Dr. Omar has not only created an amazing, globally competitive, and impactful business, but he has also created a virtuous cycle for top Egyptian scientists to succeed at home. “We are extremely proud to be able to continue supporting Nawah Scientific in its mission,” said Aly El Shalakany, CEO of the Cairo Angels Syndicate Fund.